Ursodeoxycholic Acid

Ursodeoxycholic Acid
Product Description

The most promising product for PSB Poised to attract greater demand in the marketAPI Finished Dosage FormulationDossier in CTD format Ready for License out

Amarantine Pharmaceutical LLC

  • US
  • 2015
    On CPHI since
Specifications
  • Selling Points
    Sustainability
  • Supplied from
    China
  • Measured In
    Container

Amarantine Pharmaceutical LLC

  • US
  • 2015
    On CPHI since

More Products from Amarantine Pharmaceutical LLC (2)

  • TECHNOLOGY TRANSFER - API , FINISHED DOSAGE FORMULATION

    Product TECHNOLOGY TRANSFER - API , FINISHED DOSAGE FORMULATION

    LICENCE OUT : GENERIC  We have a rich product portfolio of 300 products which offers the transformative treatments and life changing impacts for the patients.  The product portfolio covers the Intermediates, APIs and FDF for the technology transfer and commercialization. Feel ...
  • Dabigatran Etexilate Pellets

    Product Dabigatran Etexilate Pellets

    Amarantine Pharmaceuticals LLC offers a wide range of pellets products which includes dabigatran etexilate pellets. Contact us for more information.

Amarantine Pharmaceutical LLC resources (1)

  • Brochure API _ TEchnology Transfer

    Respected Sir/Madam,  We have promising portfolio for API. We have updated current API list. Please have a look and let us know if you would like to discuss furthet.  Additionally, I would like to emphasize on the following aspects which we can provide for efficient technology Transfer: -          Advanced Planning -          Fully Experienced Team -          Proven track record   -          Step by step Process We look forward to working with you.  Please contact us should you have any questions at all.   Regards     Jinjing Wang